Many patients with hepatocellular carcinoma (HCC) present with advanced disease, not
amenable to curative therapies such as surgery, transplantation or radiofrequency ablation …

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular
Carcinoma Login to Submission Gut and Liver 2021 Impact Factor 4.321 Indexed In …

Simple Summary The role of stereotactic body radiotherapy (SBRT), which can deliver high
radiation doses to focal tumors, has greatly increased in not only early-stage hepatocellular …

Background There is currently no worldwide consensus for the management of
hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). We evaluated the …

Background This study investigated the survival benefits of sorafenib vs. radiotherapy (RT)
in patients with unresectable hepatocellular carcinoma (HCC) and portal vein tumor …

Purpose We performed a meta-analysis and systematic review to compare the radiotherapy
(RT) modalities for hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) …

A large number of liver transplants have been performed for hepatocellular carcinoma
(HCC), and recurrence is increasingly encountered. The recurrence of HCC after liver …

Background Hepatocellular carcinoma (HCC) is one of the main reasons for malignancy-
related death. Portal vein tumor thrombosis (PVTT) is the most common form of …

Hepatocellular carcinoma is the fourth leading cause of cancer-related death worldwide.
Depending on the extent of disease and competing comorbidities for mortality, multiple liver …

Stereotactic Body Radiation Therapy (SBRT) is an emerging effective treatment for
hepatocellular carcinoma (HCC) associated with acceptable rates of toxicity in appropriately …